• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MDR
Click for more information
3.45% 28.0¢

MEDADVISOR LIMITED - Announcements

Market Cap $215.0M  ! watchlist Created with Sketch. Add to my watchlist

MedAdvisor Limited is an Australia-based company that is engaged in digital medication... MedAdvisor Limited is an Australia-based company that is engaged in digital medication adherence solutions. The Company's segments include Australia, the United States, the United Kingdom and Asia Operations. The Company's products suite includes Medication Management Application, PlusOne Pharmacy Software and Pharma Patient Experience Platform. The Medication Management Application connects to the pharmacy from the mobile phone. The Company's subsidiaries include MedAdvisor International Pty. Ltd., Health Enterprises 2 Pty. Ltd., MedAdvisor Welam UK Ltd., MedAdvisor Welam USA Inc. and Adheris, LLC.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
MDR Supplement to Investor Presentation - March 2019PRICE SENSITIVE22/03/19
MDR MedAdvisor Announces Agreement with Adheris Health SAPRICE SENSITIVE22/03/19
MDR Trading HaltPRICE SENSITIVE20/03/19
MDR Trading HaltPRICE SENSITIVE20/03/19
MDR MDR H1 FY2019 Financial Report & Appendix 4DPRICE SENSITIVE25/02/19
MDR MedAdvisor Quarterly Report & Appendix 4CPRICE SENSITIVE31/01/19
MDR MedAdvisor Partners with Thrivor to support PatientsPRICE SENSITIVE06/12/18
MDR MedAdvisor to launch in Asia with Zuellig PharmaPRICE SENSITIVE03/12/18
MDR PEP and International UpdatePRICE SENSITIVE26/11/18
MDR MedAdvisor Quarterly Report & Appendix 4CPRICE SENSITIVE26/10/18
MDR MedAdvisor Expands Revenue Streams in Clinical TrialsPRICE SENSITIVE10/09/18
MDR MedAdvisor FY18 Annual Report & Appendix 4EPRICE SENSITIVE31/08/18
MDR MedAdvisor and HPS Announce Integrated Medication SolutionPRICE SENSITIVE30/08/18
MDR MedAdvisor Quarterly Report & Appendix 4CPRICE SENSITIVE25/07/18 download Created with Sketch. 199.47KB
MDR Co-Marketing & Licence Agreement with US Dispense Vendor PDXPRICE SENSITIVE20/06/18 download Created with Sketch. 41.13KB
MDR MDR Signs Agreement with EBOS Subsidiary ZESTPRICE SENSITIVE15/06/18 download Created with Sketch. 36.33KB
MDR MedAdvisor to Launch Customised TerryWhite Chemmart AppPRICE SENSITIVE03/05/18
MDR MDR March 2018 Quarterly Report & Appendix 4CPRICE SENSITIVE30/04/18
MDR MDR H1 FY2018 Financial Report & Appendix 4DPRICE SENSITIVE26/02/18
MDR MDR December 2017 Quarterly Report & Appendix 4CPRICE SENSITIVE25/01/18
MDR MedAdvisor $9.5m Investment from EBOSPRICE SENSITIVE24/10/17
MDR Trading HaltPRICE SENSITIVE20/10/17
MDR MDR September 2017 Quarterly Report & Appendix 4CPRICE SENSITIVE19/10/17
MDR MDR Final FY17 Results & Appendix 4EPRICE SENSITIVE30/08/17
MDR MDR Jun-17 Quarterly Report & 4CPRICE SENSITIVE17/07/17
MDR MedAdvisor Partners with Discount Drug StoresPRICE SENSITIVE31/05/17
MDR MedAdvisor Partners with US Company iHealth LabsPRICE SENSITIVE29/05/17
MDR MDR Mar-17 Quarterly Report and 4CPRICE SENSITIVE11/04/17
MDR MedAdvisor Appendix 4D and Financial Report - Dec16PRICE SENSITIVE17/02/17
MDR Quarterly Activities Report and Appendix 4CPRICE SENSITIVE16/01/17
MDR MedAdvisor Acquires OzDocsOnlinePRICE SENSITIVE10/01/17
MDR Rapid Growth of Patient Engagement ProgramsPRICE SENSITIVE12/12/16
MDR MedAdvisor Signs Pfizer for Patient Engagement ProgramPRICE SENSITIVE08/12/16
MDR MedAdvisor Partners with Asthma AustraliaPRICE SENSITIVE29/11/16
MDR MedAdvisor Completes Healthnotes Acquisition-MDR.AX PRICE SENSITIVE31/10/16
MDR Cleansing Prospectus-MDR.AX PRICE SENSITIVE20/10/16
MDR MedAdvisor Completes $8M Oversubscribed Capital Raising-MDR.AX PRICE SENSITIVE19/10/16
MDR Trading Halt-MDR.AX PRICE SENSITIVE17/10/16
MDR Continued Growth of Tap To Refill Feature-MDR.AX PRICE SENSITIVE12/10/16
MDR MedAdvisor Partners with Osteoporosis Australia-MDR.AX PRICE SENSITIVE07/10/16
MDR September Quarterly Activities Report and Appendix 4C-MDR.AX PRICE SENSITIVE05/10/16
MDR MedAdvisor to Acquire Healthnotes to Accelerate Growth-MDR.AX PRICE SENSITIVE31/08/16
MDR Trading Halt-MDR.AX PRICE SENSITIVE29/08/16
MDR MedAdvisor launches new NDSS feature with Diabetes Aust-MDR.AX PRICE SENSITIVE28/08/16
MDR Appendix 4E and Preliminary Financial Report-MDR.AX PRICE SENSITIVE28/08/16
MDR Appendix 4E and Preliminary Financial Report-MDR.AX PRICE SENSITIVE26/08/16
MDR MedAdvisor launches new NDSS feature with Diabetes Aust-MDR.AX PRICE SENSITIVE25/08/16
MDR Glaucoma Australia Partnership to assist 300,000 Australians-MDR.AX PRICE SENSITIVE15/08/16
MDR Quarterly Activities Report and Appendix 4C - June 16-MDR.AX PRICE SENSITIVE29/07/16
MDR Major Biopharmaceutical Signs to Patient Engagement Program-MDR.AX PRICE SENSITIVE01/07/16
MDR Strong Growth in Key Business Drivers-MDR.AX PRICE SENSITIVE29/06/16
MDR GlaxoSmithKline Extends Service Agreement with MedAdvisor-MDR.AX PRICE SENSITIVE16/06/16
MDR Sales Channel Secured with Arrow Pharmaceuticals-MDR.AX PRICE SENSITIVE01/06/16
MDR Novartis Pharmaceuticals Australia to use MedAdvisor-MDR.AX PRICE SENSITIVE30/05/16
MDR MDR Quarterly Activities Report and Appendix 4C-MDR.AX PRICE SENSITIVE29/04/16
MDR MedAdvisor & Arrow to launch strategic partnershipPRICE SENSITIVE21/03/16
MDR MedAdvisor launches 1st phase of highly anticipated GP LinkPRICE SENSITIVE18/03/16
MDR Appendix 4D - MedAdvisor Half Year Financial Results Dec-15PRICE SENSITIVE29/02/16
MDR QUARTERLY ACTIVITIES REPORT and APPENDIX 4CPRICE SENSITIVE29/01/16
MDR MDR reaches 1 million prescription milestonePRICE SENSITIVE22/01/16
MDR Signs partnership agreement with Epilepsy Queensland Inc.PRICE SENSITIVE08/01/16
MDR Reinstatement to Official Quotation - 1 December 2015PRICE SENSITIVE30/11/15
MDR Supplement to Investor Presentation - March 2019
22/03/19PRICE SENSITIVE
MDR MedAdvisor Announces Agreement with Adheris Health SA
22/03/19PRICE SENSITIVE
MDR Trading Halt
20/03/19PRICE SENSITIVE
MDR Trading Halt
20/03/19PRICE SENSITIVE
MDR MDR H1 FY2019 Financial Report & Appendix 4D
25/02/19PRICE SENSITIVE
MDR MedAdvisor Quarterly Report & Appendix 4C
31/01/19PRICE SENSITIVE
MDR MedAdvisor Partners with Thrivor to support Patients
06/12/18PRICE SENSITIVE
MDR MedAdvisor to launch in Asia with Zuellig Pharma
03/12/18PRICE SENSITIVE
MDR PEP and International Update
26/11/18PRICE SENSITIVE
MDR MedAdvisor Quarterly Report & Appendix 4C
26/10/18PRICE SENSITIVE
MDR MedAdvisor Expands Revenue Streams in Clinical Trials
10/09/18PRICE SENSITIVE
MDR MedAdvisor FY18 Annual Report & Appendix 4E
31/08/18PRICE SENSITIVE
MDR MedAdvisor and HPS Announce Integrated Medication Solution
30/08/18PRICE SENSITIVE
MDR MedAdvisor Quarterly Report & Appendix 4C
25/07/18PRICE SENSITIVE download Created with Sketch. 199.47KB
MDR Co-Marketing & Licence Agreement with US Dispense Vendor PDX
20/06/18PRICE SENSITIVE download Created with Sketch. 41.13KB
MDR MDR Signs Agreement with EBOS Subsidiary ZEST
15/06/18PRICE SENSITIVE download Created with Sketch. 36.33KB
MDR MedAdvisor to Launch Customised TerryWhite Chemmart App
03/05/18PRICE SENSITIVE
MDR MDR March 2018 Quarterly Report & Appendix 4C
30/04/18PRICE SENSITIVE
MDR MDR H1 FY2018 Financial Report & Appendix 4D
26/02/18PRICE SENSITIVE
MDR MDR December 2017 Quarterly Report & Appendix 4C
25/01/18PRICE SENSITIVE
MDR MedAdvisor $9.5m Investment from EBOS
24/10/17PRICE SENSITIVE
MDR Trading Halt
20/10/17PRICE SENSITIVE
MDR MDR September 2017 Quarterly Report & Appendix 4C
19/10/17PRICE SENSITIVE
MDR MDR Final FY17 Results & Appendix 4E
30/08/17PRICE SENSITIVE
MDR MDR Jun-17 Quarterly Report & 4C
17/07/17PRICE SENSITIVE
MDR MedAdvisor Partners with Discount Drug Stores
31/05/17PRICE SENSITIVE
MDR MedAdvisor Partners with US Company iHealth Labs
29/05/17PRICE SENSITIVE
MDR MDR Mar-17 Quarterly Report and 4C
11/04/17PRICE SENSITIVE
MDR MedAdvisor Appendix 4D and Financial Report - Dec16
17/02/17PRICE SENSITIVE
MDR Quarterly Activities Report and Appendix 4C
16/01/17PRICE SENSITIVE
MDR MedAdvisor Acquires OzDocsOnline
10/01/17PRICE SENSITIVE
MDR Rapid Growth of Patient Engagement Programs
12/12/16PRICE SENSITIVE
MDR MedAdvisor Signs Pfizer for Patient Engagement Program
08/12/16PRICE SENSITIVE
MDR MedAdvisor Partners with Asthma Australia
29/11/16PRICE SENSITIVE
MDR MedAdvisor Completes Healthnotes Acquisition-MDR.AX
31/10/16PRICE SENSITIVE
MDR Cleansing Prospectus-MDR.AX
20/10/16PRICE SENSITIVE
MDR MedAdvisor Completes $8M Oversubscribed Capital Raising-MDR.AX
19/10/16PRICE SENSITIVE
MDR Trading Halt-MDR.AX
17/10/16PRICE SENSITIVE
MDR Continued Growth of Tap To Refill Feature-MDR.AX
12/10/16PRICE SENSITIVE
MDR MedAdvisor Partners with Osteoporosis Australia-MDR.AX
07/10/16PRICE SENSITIVE
MDR September Quarterly Activities Report and Appendix 4C-MDR.AX
05/10/16PRICE SENSITIVE
MDR MedAdvisor to Acquire Healthnotes to Accelerate Growth-MDR.AX
31/08/16PRICE SENSITIVE
MDR Trading Halt-MDR.AX
29/08/16PRICE SENSITIVE
MDR MedAdvisor launches new NDSS feature with Diabetes Aust-MDR.AX
28/08/16PRICE SENSITIVE
MDR Appendix 4E and Preliminary Financial Report-MDR.AX
28/08/16PRICE SENSITIVE
MDR Appendix 4E and Preliminary Financial Report-MDR.AX
26/08/16PRICE SENSITIVE
MDR MedAdvisor launches new NDSS feature with Diabetes Aust-MDR.AX
25/08/16PRICE SENSITIVE
MDR Glaucoma Australia Partnership to assist 300,000 Australians-MDR.AX
15/08/16PRICE SENSITIVE
MDR Quarterly Activities Report and Appendix 4C - June 16-MDR.AX
29/07/16PRICE SENSITIVE
MDR Major Biopharmaceutical Signs to Patient Engagement Program-MDR.AX
01/07/16PRICE SENSITIVE
MDR Strong Growth in Key Business Drivers-MDR.AX
29/06/16PRICE SENSITIVE
MDR GlaxoSmithKline Extends Service Agreement with MedAdvisor-MDR.AX
16/06/16PRICE SENSITIVE
MDR Sales Channel Secured with Arrow Pharmaceuticals-MDR.AX
01/06/16PRICE SENSITIVE
MDR Novartis Pharmaceuticals Australia to use MedAdvisor-MDR.AX
30/05/16PRICE SENSITIVE
MDR MDR Quarterly Activities Report and Appendix 4C-MDR.AX
29/04/16PRICE SENSITIVE
MDR MedAdvisor & Arrow to launch strategic partnership
21/03/16PRICE SENSITIVE
MDR MedAdvisor launches 1st phase of highly anticipated GP Link
18/03/16PRICE SENSITIVE
MDR Appendix 4D - MedAdvisor Half Year Financial Results Dec-15
29/02/16PRICE SENSITIVE
MDR QUARTERLY ACTIVITIES REPORT and APPENDIX 4C
29/01/16PRICE SENSITIVE
MDR MDR reaches 1 million prescription milestone
22/01/16PRICE SENSITIVE
MDR Signs partnership agreement with Epilepsy Queensland Inc.
08/01/16PRICE SENSITIVE
MDR Reinstatement to Official Quotation - 1 December 2015
30/11/15PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
28.0¢ 		Change
-0.010(3.45%) 		Mkt cap ! $215.0M
Open High Low Value Volume
29.0¢ 29.0¢ 27.5¢ $44.27K 156.5K

Buyers (Bids)

No. Vol. Price($)
2 34014 27.5¢
 

Sellers (Offers)

Price($) Vol. No.
28.5¢ 15493 3
View Market Depth
Last trade - 11.02am 15/11/2024 (20 minute delay) ?
Last
28.0¢ 		  Change
-0.010 ( 1.75 %)
Open High Low Volume
28.0¢ 28.5¢ 27.5¢ 28848
Last updated 12.39pm 15/11/2024 ?
MDR (ASX) Chart

Top Stories

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Blue Star Helium (ASX:BNL) has won approval from Colorado regulators to drill five fresh helium wells at its flagship.
Cyclone signs MOU with Vale for development of Iron Bear play Cyclone Metals Lt has signed a Memorandum of Understanding with Vale S.A to support development of the former's iron ore project in Canada
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.